ArticleLeukemia & lymphoma2020

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.

Christopher Pleyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.